The impact of cancer treatments was also found in the serum levels of CCNH–C5orf30: 97.1% (33/34) of patients with HCC experienced a drop in the serum levels of the transcript after cancer treatment. The gene discussed is CCNH; the disease is hepatocellular carcinoma.